Inventor · disambiguated record
David R. Milich
Also filed as: MILICH DAVID · MILICH DAVID R
14 granted patents·6 pending applications·1,185 citations·filing 1984–2020
94Inventor score
Files withVACCINE RES INST OF SAN DIEGO6SCRIPPS CLINIC RES5VLP BIOTECH INC4MILICH DAVID R1NOVARTIS VACCINES & DIAGNOSTIC1
Top patents by PatentIndex Score
20 records- 0196US4599230ASynthetic hepatitis B virus vaccine including both T cell and B cell determinantsSCRIPPS CLINIC RES·Filed 1984·Granted Jul 8, 1986·388 cites·19 claims
- 0295US4599231ASynthetic hepatitis B virus vaccine including both T cell and B cell determinantsSCRIPPS CLINIC RES·Filed 1984·Granted Jul 8, 1986·359 cites·22 claims
- 0390US5143726AT cell epitopes of the hepatitis B virus nucleocapsid proteinSCRIPPS RESEARCH INST·Filed 1989·Granted Sep 1, 1992·120 cites·5 claims
- 0489US7811576B2Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereofVACCINE RES INST OF SAN DIEGO·Filed 2008·Granted Oct 12, 2010·9 cites·30 claims
- 0589US4818527AT cell epitopes of the hepatitis B virus nucleocapsid proteinSCRIPPS CLINIC RES·Filed 1986·Granted Apr 4, 1989·104 cites·23 claims
- 0686US4882145AT cell epitopes of the hepatitis B virus nucleocapsid proteinSCRIPPS CLINIC RES·Filed 1987·Granted Nov 21, 1989·88 cites·2 claims
- 0784US7320795B2Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereofVACCINE RES INST OF SAN DIEGO·Filed 2003·Granted Jan 22, 2008·19 cites·28 claims
- 0881US7144712B2Human hepatitis B virus core proteins as vaccine platforms and methods of use thereofVACCINE RES INST OF SAN DIEGO·Filed 2003·Granted Dec 5, 2006·13 cites·67 claims
- 0977US7883843B2Hepatitis virus core proteins as vaccine platforms and methods of use thereofVACCINE RES INST OF SAN DIEGO·Filed 2004·Granted Feb 8, 2011·11 cites·6 claims
- 1077US4683136AProteinaceous antigens with conformation-independent and conformation-dependent determinantsSCRIPPS CLINIC RES·Filed 1985·Granted Jul 28, 1987·56 cites·8 claims
- 1163US10300124B2Rodent hepadnavirus cores with reduced carrier-specific antigenicityVLP BIOTECH INC·Filed 2014·Granted May 28, 2019·1 cites·17 claims
- 1262US2008138892A1Hepadna virus core proteins as vaccine platforms and methods of use thereofVACCINE RES INST OF SAN DIEGO·Filed 2006·Application pending·0 cites
- 1351US2005208068A1Malaria immunogen and vaccineMILICH DAVID R·Filed 2004·Application pending·0 cites
- 1450US2010203074A1Compositions and methods for treating intracellular diseasesSALLBERG MATTI·Filed 2010·Application pending·0 cites
- 1547US2011206724A1Hepatitis virus core proteins as vaccine platforms and methods of use thereofVACCINE RES INST OF SAN DIEGO·Filed 2010·Application pending·0 cites
- 1646US5726011AMethod for diagnosing chronic hepatitis B virus infectionUNIV VIRGINIA COMMONWEALTH·Filed 1994·Granted Mar 10, 1998·14 cites·11 claims
- 1745US2022411475A1Hybrid virus-like particles and use thereof as a therapeutic hepatitis b vaccineVLP BIOTECH INC·Filed 2020·Application pending·0 cites
- 1837US7763589B2Compositions and methods for treating intracellular diseasesNOVARTIS VACCINES & DIAGNOSTIC·Filed 1999·Granted Jul 27, 2010·3 cites·5 claims
- 1935US11235045B2Hybrid hepadnavirus cores carrying multiple malaria parasite epitopesVLP BIOTECH INC·Filed 2018·Granted Feb 1, 2022·0 cites·20 claims
- 2031US2016039883A1Palivizumab epitope-based virus-like particlesVLP BIOTECH INC·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →